蛋白组学新秀5000万美元超额募资,Illumina又心动了

动脉网
Jan 14

2026年1月11日,蛋白组学领域传来大消息,Alamar Biosciences宣布完成超额认购的可转换票据融资,筹集超5000万美元新资金,新投资者有T. Rowe Price Investment Management, Inc.等,现有投资者Illumina Ventures等也参与其中。此前,Alamar旗下ARGO HT装机已突破100台。此次融资将支持其精准蛋白质组学平台商业推进,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10